You are here

  • Home
  • Archive
  • Volume 11, Issue 4
  • Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy

Article info

Article menu

This article has a correction. Please see:

Clinical/translational cancer immunotherapy
Original research
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy

Authors

  • Sandhya Sharma Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Mae Woods Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Naren U Mehta Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Tim Sauer Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Kathan S Parikh Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Michael Schmueck-Henneresse Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USABerlin Institute of Health (BIH) at Charité – Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, Berlin, Germany PubMed articlesGoogle scholar articles
  • Huimin Zhang Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Birju Mehta Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Malcolm K Brenner Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USADan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USADepartment of Medicine, Baylor College of Medicine, Houston, Texas, USADepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Helen E Heslop Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USADan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USADepartment of Medicine, Baylor College of Medicine, Houston, Texas, USADepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles
  • Cliona M Rooney Graduate Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, Texas, USACenter for Cell and Gene Therapy, Baylor College of Medicine, Texas Children’s Hospital, and Houston Methodist Hospital, Houston, Texas, USADan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USADepartment of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USADepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USADepartment of Pathology-Immunology, Baylor College of Medicine, Houston, Texas, USA PubMed articlesGoogle scholar articles

Citation

Sharma S, Woods M, Mehta NU, et al
Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy
Journal for ImmunoTherapy of Cancer 2023;11:e006267. doi: 10.1136/jitc-2022-006267
Online issue publication 
December 07, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.